CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Maravai Life Sciences Inc. - MRVI CFD

    5.08
    0.78%
    0.07
    Low: 5.01
    High: 5.12
    Market Trading Hours* (UTC) Open now
    Closes on Friday at 21:00

    Mon - Fri: 14:30 - 21:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Maravai LifeSciences Holdings Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 5.15
    Open* 5.11
    1-Year Change* -59.73%
    Day's Range* 5.01 - 5.12
    52 wk Range 4.52-16.90
    Average Volume (10 days) 4.61M
    Average Volume (3 months) 56.43M
    Market Cap 1.24B
    P/E Ratio 10.45
    Shares Outstanding 251.28M
    Revenue 419.52M
    EPS 0.47
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date Feb 20, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 7, 2023 5.15 -0.08 -1.53% 5.23 5.27 5.08
    Dec 6, 2023 5.32 0.18 3.50% 5.14 5.46 5.09
    Dec 5, 2023 5.17 -0.08 -1.52% 5.25 5.32 5.13
    Dec 4, 2023 5.35 0.09 1.71% 5.26 5.59 5.26
    Dec 1, 2023 5.36 0.35 6.99% 5.01 5.38 4.89
    Nov 30, 2023 5.07 -0.09 -1.74% 5.16 5.23 5.04
    Nov 29, 2023 5.16 0.02 0.39% 5.14 5.38 5.09
    Nov 28, 2023 5.09 0.07 1.39% 5.02 5.21 4.94
    Nov 27, 2023 5.09 -0.10 -1.93% 5.19 5.31 5.06
    Nov 24, 2023 5.32 0.28 5.56% 5.04 5.47 5.04
    Nov 22, 2023 5.14 0.27 5.54% 4.87 5.20 4.87
    Nov 21, 2023 4.89 0.02 0.41% 4.87 5.00 4.65
    Nov 20, 2023 4.90 0.01 0.20% 4.89 4.98 4.87
    Nov 17, 2023 4.99 -0.14 -2.73% 5.13 5.13 4.84
    Nov 16, 2023 5.08 -0.02 -0.39% 5.10 5.16 4.89
    Nov 15, 2023 5.16 -0.01 -0.19% 5.17 5.52 5.10
    Nov 14, 2023 5.16 0.22 4.45% 4.94 5.29 4.94
    Nov 13, 2023 4.93 -0.13 -2.57% 5.06 5.15 4.89
    Nov 10, 2023 5.11 0.54 11.82% 4.57 5.11 4.53
    Nov 9, 2023 4.65 -0.04 -0.85% 4.69 4.76 4.49

    Maravai Life Sciences Inc. Events

    Time (UTC) Country Event
    Tuesday, February 20, 2024

    Time (UTC)

    21:00

    Country

    US

    Event

    Q4 2023 Maravai LifeSciences Holdings Inc Earnings Release
    Q4 2023 Maravai LifeSciences Holdings Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 883.001 799.24 284.098 143.14 123.833
    Revenue 883.001 799.24 284.098 143.14 123.833
    Cost of Revenue, Total 168.957 140.561 79.649 66.849 60.765
    Gross Profit 714.044 658.679 204.449 76.291 63.068
    Total Operating Expense 308.993 244.595 171.788 119.152 113.019
    Selling/General/Admin. Expenses, Total 129.259 100.064 94.245 40.354 33.194
    Research & Development 15.569 9.319 1.704 3.627 4.499
    Depreciation / Amortization 2.8 5.9 7.6 8 8
    Unusual Expense (Income) 0.208 -11.249 -11.41 0 5.622
    Other Operating Expenses, Total -7.8 0 0 0.322 0.939
    Operating Income 574.008 554.645 112.31 23.988 10.814
    Interest Income (Expense), Net Non-Operating -18.076 -30.26 -30.74 -29.959 -27.399
    Other, Net -4.46 6.38 0.126 0.118 0.087
    Net Income Before Taxes 551.472 530.765 81.696 -5.853 -16.498
    Net Income After Taxes 490.663 469.25 78.816 -5.201 -16.915
    Minority Interest -270.458 -287.213 13.342 2.4 4.446
    Net Income Before Extra. Items 220.205 182.037 92.158 -2.801 -12.469
    Net Income 220.205 182.037 92.158 -2.801 -12.469
    Total Adjustments to Net Income -15.27 -5.68 -5.259
    Income Available to Common Excl. Extra. Items 220.205 182.037 76.888 -8.481 -17.728
    Income Available to Common Incl. Extra. Items 220.205 182.037 76.888 -8.481 -17.728
    Diluted Net Income 426.276 402.356 76.888 -8.481 -17.728
    Diluted Weighted Average Shares 255.323 257.803 257.621 257.621 257.621
    Diluted EPS Excluding Extraordinary Items 1.66956 1.56071 0.29845 -0.03292 -0.06881
    Dividends per Share - Common Stock Primary Issue 0 0
    Diluted Normalized EPS 1.7403 1.52746 0.27165 -0.03292 -0.05463
    Dilution Adjustment 206.071 220.319
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 68.914 79.025 204.713 191.263 487.025
    Revenue 68.914 79.025 204.713 191.263 487.025
    Cost of Revenue, Total 43.273 33.676 53.253 38.176 77.528
    Gross Profit 25.641 45.349 151.46 153.087 409.497
    Total Operating Expense 80.528 76.492 95.467 74.36 139.166
    Selling/General/Admin. Expenses, Total 34.677 37.971 37.203 30.095 59.761
    Research & Development 4.194 4.145 4.411 5.389 7.969
    Depreciation / Amortization 0.7 0.7 0.6 0.7 1.5
    Unusual Expense (Income) 0 0 0 0 0.208
    Operating Income -11.614 2.533 109.246 116.903 347.859
    Interest Income (Expense), Net Non-Operating -0.231 -5.788 -7.842 -3.136 -7.098
    Other, Net -1.519 -1.268 -5.528 -0.004 1.072
    Net Income Before Taxes -13.364 -4.523 95.876 113.763 341.833
    Net Income After Taxes -11.943 -1.348 87.429 99.653 303.581
    Minority Interest 5.402 1.281 -49.795 -55.184 -165.479
    Net Income Before Extra. Items -6.541 -0.067 37.634 44.469 138.102
    Net Income -6.541 -0.067 37.634 44.469 138.102
    Income Available to Common Excl. Extra. Items -6.541 -0.067 37.634 44.469 138.102
    Income Available to Common Incl. Extra. Items -6.541 -0.067 37.634 44.469 138.102
    Diluted Net Income -6.541 -0.067 75.161 44.487 306.628
    Diluted Weighted Average Shares 131.864 131.739 131.626 131.651 193.487
    Diluted EPS Excluding Extraordinary Items -0.0496 -0.00051 0.57102 0.33792 1.58475
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.03069 0.02789 0.58965 0.35893 1.63859
    Total Adjustments to Net Income
    Dilution Adjustment 37.527 0.018 168.526
    Other Operating Expenses, Total -2.316 0 0 -7.8
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 847.902 740.039 331.598 60.552 53.802
    Cash and Short Term Investments 632.138 551.272 236.184 24.7 21.866
    Cash 632.138 551.272 236.184 24.7 21.866
    Total Receivables, Net 146.814 117.512 51.218 18.83 15.991
    Accounts Receivable - Trade, Net 138.624 117.512 51.218 18.83 15.991
    Total Inventory 43.152 51.557 33.301 14.202 14.308
    Prepaid Expenses 25.798 19.698 10.895 2.82 1.637
    Total Assets 2282.31 1918.28 1270.69 577.796 539.676
    Property/Plant/Equipment, Total - Net 116.59 95.427 101.305 94.311 42.578
    Property/Plant/Equipment, Total - Gross 136.092 107.959 111.952 102.41 31.492
    Accumulated Depreciation, Total -19.502 -12.532 -10.647 -8.099 -4.289
    Goodwill, Net 283.668 152.766 224.275 224.275 224.275
    Intangibles, Net 216.663 117.571 177.656 197.853 218.127
    Other Long Term Assets, Total 817.492 812.473 435.857 0.805 0.894
    Total Current Liabilities 110.144 93.777 130.778 29.562 35.919
    Accounts Payable 5.991 8.154 8.171 7.478 3.604
    Accrued Expenses 50.629 29.34 29.014 16.515 11.147
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 5.44 6 6 2.5 2.5
    Other Current Liabilities, Total 48.084 50.283 87.593 3.069 18.668
    Total Liabilities 1737.1 1602.78 1182.18 436.4 395.271
    Total Long Term Debt 521.997 524.591 584.781 387.702 337.389
    Long Term Debt 521.997 524.591 528.614 334.783 335.55
    Capital Lease Obligations 0 56.167 52.919 1.839
    Deferred Income Tax 0 8.609 14.697 15.856
    Minority Interest 360.025 229.862 66.235 3.231 3.611
    Other Liabilities, Total 744.931 754.547 391.777 1.208 2.496
    Total Equity 545.218 315.499 88.511 141.396 144.405
    Common Stock 2.554 2.552 2.576 183.91 182.809
    Retained Earnings (Accumulated Deficit) 404.766 184.561 0.854 -42.381 -38.237
    Other Equity, Total 0 -0.044 -0.133 -0.167
    Total Liabilities & Shareholders’ Equity 2282.31 1918.28 1270.69 577.796 539.676
    Total Common Shares Outstanding 255.361 255.157 257.621 257.621 257.621
    Additional Paid-In Capital 137.898 128.386 85.125
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 700.865 699.312 765.513 847.902 835.526
    Cash and Short Term Investments 579.605 580.176 628.273 632.138 617.446
    Cash 579.605 580.176 628.273 632.138 617.446
    Total Receivables, Net 49.202 49.219 56.889 146.814 132.224
    Accounts Receivable - Trade, Net 45.674 48.987 56.273 138.624 114.069
    Total Inventory 49.142 47.402 54.819 43.152 62.424
    Prepaid Expenses 22.916 22.515 25.532 25.798 23.432
    Total Assets 2267.55 2264.44 2315.39 2282.31 2248.9
    Property/Plant/Equipment, Total - Net 216.424 206.633 154.865 116.59 102.538
    Goodwill, Net 326.029 326.459 326.569 283.668 283.535
    Intangibles, Net 227.856 234.726 241.578 216.663 222.899
    Other Long Term Assets, Total 796.379 797.307 826.863 817.492 804.401
    Total Current Liabilities 78.253 74.919 124.896 110.144 115.655
    Accounts Payable 9.424 6.658 4.784 5.991 9.459
    Accrued Expenses 56.042 50.344 66.035 50.629 48.181
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 6.036 6 5.74 5.44 5.44
    Other Current Liabilities, Total 6.751 11.917 48.337 48.084 52.575
    Total Liabilities 1748.26 1743.87 1793.87 1737.1 1745.14
    Total Long Term Debt 551.597 552.572 537.73 521.997 522.824
    Long Term Debt 519.52 520.336 521.161 521.997 522.824
    Capital Lease Obligations 32.077 32.236 16.569
    Deferred Income Tax 6.69 8.512 8.68
    Minority Interest 372.987 377.067 379.121 360.025 337.908
    Other Liabilities, Total 738.732 730.796 743.444 744.931 768.751
    Total Equity 519.294 520.571 521.517 545.218 503.761
    Common Stock 2.51 2.51 2.509 2.554 2.552
    Additional Paid-In Capital 125.088 119.903 114.309 137.898 134.077
    Retained Earnings (Accumulated Deficit) 391.696 398.158 404.699 404.766 367.132
    Other Equity, Total
    Total Liabilities & Shareholders’ Equity 2267.55 2264.44 2315.39 2282.31 2248.9
    Total Common Shares Outstanding 251.039 250.995 250.883 255.361 255.209
    Other Current Assets, Total
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 490.663 469.25 78.816 -5.201 -16.915
    Cash From Operating Activities 535.977 368.57 152.187 24.115 -0.186
    Cash From Operating Activities 7.566 6.413 5.517 3.81 2.225
    Amortization 24.269 18.339 20.32 20.274 20.122
    Deferred Taxes 42.318 46.904 -5.464 -1.159 0.317
    Non-Cash Items 16.243 4.295 17.105 4.101 9.906
    Cash Taxes Paid 23.032 22.473 5.006 -0.802 -0.097
    Cash Interest Paid 20.198 27.234 28.916 28.728 25.678
    Changes in Working Capital -45.082 -176.631 35.893 2.29 -15.841
    Cash From Investing Activities -267.612 105.655 6.068 -17.148 -3.451
    Capital Expenditures -17.09 -14.85 -25.408 -17.148 -3.611
    Other Investing Cash Flow Items, Total -250.522 120.505 31.476 0 0.16
    Cash From Financing Activities -187.499 -159.049 53.212 -4.167 -9.167
    Financing Cash Flow Items -184.417 -154.758 -444.983 -1.527 -64.595
    Issuance (Retirement) of Debt, Net -5.44 -6 196.924 -2.64 55.428
    Foreign Exchange Effects 0 -0.088 0.017 0.034 -0.069
    Net Change in Cash 80.866 315.088 211.484 2.834 -12.873
    Issuance (Retirement) of Stock, Net 2.358 1.709 301.271
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -1.348 490.663 403.234 303.581 146.86
    Cash From Operating Activities 85.074 535.977 436.642 326.583 162.304
    Cash From Operating Activities 2.08 7.566 5.604 3.747 1.855
    Amortization 6.765 24.269 18.033 11.779 5.527
    Deferred Taxes -1.52 42.318 35.307 26.073 13.217
    Non-Cash Items 10.756 16.243 3.785 0.769 3.083
    Cash Taxes Paid 0.521 23.032 19.581 13.856 0.914
    Cash Interest Paid 9.593 20.198 11.416 6.132 1.373
    Changes in Working Capital 68.341 -45.082 -29.321 -19.366 -8.238
    Cash From Investing Activities -69.73 -267.612 -249.092 -243.245 -241.584
    Capital Expenditures -7.868 -17.09 -10.876 -4.409 -2.748
    Other Investing Cash Flow Items, Total -61.862 -250.522 -238.216 -238.836 -238.836
    Cash From Financing Activities -19.209 -187.499 -121.376 -83.934 -40.523
    Financing Cash Flow Items -17.516 -184.417 -119.289 -82.477 -39.889
    Issuance (Retirement) of Stock, Net -0.333 2.358 1.993 1.263 0.726
    Issuance (Retirement) of Debt, Net -1.36 -5.44 -4.08 -2.72 -1.36
    Foreign Exchange Effects 0 0 0 0
    Net Change in Cash -3.865 80.866 66.174 -0.596 -119.803
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    GTCR Golder Rauner, LLC Private Equity 16.4345 21681033 0 2023-06-30 LOW
    MFS Investment Management Investment Advisor/Hedge Fund 8.2802 10923597 -581604 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.9861 10535588 -3628 2023-06-30 LOW
    Thrivent Asset Management, LLC Investment Advisor 6.2954 8305132 115334 2023-06-30 LOW
    Millennium Management LLC Hedge Fund 5.2879 6975927 6754514 2023-10-20 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 3.7932 5004116 -62895 2023-06-30 LOW
    Mackenzie Financial Corporation Investment Advisor/Hedge Fund 3.7377 4930841 1384455 2023-09-30 LOW
    Two Sigma Investments, LP Hedge Fund 3.6721 4844318 1535009 2023-06-30 HIGH
    12 West Capital Management, L.P. Hedge Fund 2.5483 3361836 793066 2023-06-30 MED
    ClearBridge Investments, LLC Investment Advisor/Hedge Fund 2.3559 3107963 -132200 2023-06-30 LOW
    Alyeska Investment Group, L.P. Hedge Fund 1.8767 2475747 691686 2023-06-30 HIGH
    Renaissance Technologies LLC Hedge Fund 1.8504 2441175 -751325 2023-06-30 HIGH
    Susquehanna International Group, LLP Investment Advisor 1.8489 2439078 1765967 2023-06-30 MED
    Ostrum Asset Management Investment Advisor 1.6599 2189817 1236958 2023-06-30 MED
    Citi Investment Research (US) Research Firm 1.6578 2187052 -93129 2023-06-30 MED
    Pacer Advisors, Inc. Investment Advisor 1.5727 2074794 34601 2023-06-30 MED
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4837 1957399 929575 2022-12-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3906 1834493 -5975 2023-06-30 LOW
    Braidwell LP Hedge Fund 1.368 1804700 1804700 2023-06-30 HIGH
    Jennison Associates LLC Investment Advisor/Hedge Fund 1.348 1778391 0 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Maravai Life Sciences Inc. Company profile

    Maravai Life Sciences Inc. provides in vitro diagnostic products, diagnostic laboratory services, and life sciences tools. The company was founded in 2014 and is based in San Diego, California.
    Industry: Bio Diagnostics & Testing

    10770 Wateridge Circle Suite 200
    Suite 200
    SAN DIEGO
    CALIFORNIA 92121
    US

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    BTC/USD

    43,825.85 Price
    +1.120% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    XRP/USD

    0.67 Price
    +1.460% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Oil - Crude

    71.28 Price
    +2.470% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    US100

    16,097.40 Price
    +0.340% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading